Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Altris AI logo — AI Decision Support for OCT Analysis that elevates Ophthalmo...

Altris AI

AI Decision Support for OCT Analysis that elevates Ophthalmology, Research, and Optometry.

Founded 2018 United States Chicago, United States 33 employees Seed Total: $1.00M AI, Biotechnology +4

General Information

Company Name Altris AI
Founded Year 2018
Location United States Chicago, United States
Employees 33
Industries AI, Biotechnology, Education +3
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Altris AI. To contact Altris AI, visit altris.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Altris AI compare?

A PDF of Altris AI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Altris AI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Altris AI

Altris AI, founded in 2018, is a cutting-edge web platform specializing in the analysis of OCT scans using artificial intelligence. This innovative tool distinguishes itself by detecting over 70 retina pathologies, including rare conditions, ensuring both an expedited and more precise OCT examination process.

The company's offering is particularly appealing due to its compliance with GDPR standards, ensuring encrypted and secure data management with forthcoming FDA clearance. Enhanced accuracy and diagnostic speed have led to its adoption in over 30 eye clinics and optometry centers worldwide.

Based in the United States, Altris AI operates within diverse industries, including AI, Biotechnology, and Health Care. The company recently received investment from Network. VC during a funding round on August 14, 2023. This investment underscores its potential for significant growth in the burgeoning AI-driven healthcare segment.

Business keywords: algorithm, OCT scan analysis, retina pathologies, diagnostic tool, data encryption, GDPR compliance, CE certificate, FDA clearance, optometry centers, medical imaging, digital health

Services & Products

AI Enhanced OCT Scan Analysis
Early Disease Detection
Quantitative Biomarker Measurements
Clinical Decision Support
Historical Data Analysis

Target Customers

Ophthalmologists Optometrists Ophthalmic Clinics Research Institutions Optometry Clinics Eye Care Specialists

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Undisclosed 1
SID Venture Partners
SID Venture Partners
01 Jan 2025
Round Undisclosed 1
Network VC
01 Aug 2023
Seed $1.00M 7
Brinc Runa Capital The University of Chicago
Brinc, Runa Capital +5
01 Dec 2022
Seed Undisclosed 1
Brinc
Brinc
01 Jul 2021

Altris AI Alternatives & Competitors

View All Alternatives
Altris AI vs
Biotronics3D Ltd
Biotronics3D Ltd United Kingdom

The Next-Generation Imaging Platform

Venture round
33 employees
Biotechnology, Computing
Compare Altris AI vs Biotronics3D Ltd
Altris AI vs
Inmedix Inc
Inmedix Inc United States

Bringing accurate and safe HRV meeting FDA standards to clinicians.

Seed
4 employees
Biotechnology, Health Care
Compare Altris AI vs Inmedix Inc
Altris AI vs
Casana
Casana United States

Meet the future of in-home health monitoring, where you’d least expect it.

Series B
48 employees
AI, Health Care
View all alternatives

FAQ About Altris AI

AI Decision Support for OCT Analysis that elevates Ophthalmology, Research, and Optometry.
Altris AI was founded in 2018.
Altris AI is headquartered in Chicago, United States.
Altris AI operates in AI, Biotechnology, Education, Health Care, Mobile and Machine Learning. Its work centres on algorithm, OCT scan analysis, retina pathologies and diagnostic tool. Its customers include Ophthalmologists, Optometrists and Ophthalmic Clinics.
Altris AI has approximately 33 employees.
Altris AI has completed 4 funding rounds, raising a total of $1.00M. The latest funding stage is Seed.
Altris AI offers: AI Enhanced OCT Scan Analysis, Early Disease Detection, Quantitative Biomarker Measurements, Clinical Decision Support, Historical Data Analysis.
Top alternatives and competitors to Altris AI include Biotronics3D Ltd, Inmedix Inc, Casana, Biobeat, Envisionit Deep AI®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Altris AI and Biotronics3D Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Altris AI, https://bouncewatch.com/company/altris-ai, updated 24 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes